"Cardiology Associates offers medical and diagnostic treatments and minimally invasive procedures to treat heart and vascular disease. Our specialized team of 30 cardiologists treat pediatric and adult patients with heart disease, heart failure, peripheral artery disease, arrhythmia's (Afib), structural heart disease, and congenital heart defects. Our state-of-the art advanced diagnostic imaging with dedicated Cardiac PET and CT for the heart and peripheral vascular system, allows for more accurate diagnosis and treatment. Our 5 fellowship trained electrophysiologists provide the most comprehensive arrhythmia care using medical therapies and minimally invasive ablation procedures and implants for pacemaker and defibrillators in the area."

During the past decade, Cardiology Associates of Mobile, Inc. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiology Associates of Mobile, Inc." #1 sponsor was "Abbott Medical Devices" with 5 trials, followed by "Horizons International Peripheral Group" with 3 trials sponsored, "C. R. Bard" with 1 trials sponsored, "CTI-1, LLC" with 1 trials sponsored and "CVRx, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiology Associates of Mobile, Inc." #1 collaborator was "Advanced Catheter Therapies, Inc." with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Cardiology Associates of Mobile, Inc." are "Bradycardia" (2 trials), "Congestive Heart Failure" (2 trials), "Coronary Artery Disease" (2 trials), "Mitral Valve Regurgitation" (2 trials) and "Peripheral Arterial Disease" (2 trials). Many other conditions were trialed in "Cardiology Associates of Mobile, Inc." in a lesser frequency.

Most popular intervention types in "Cardiology Associates of Mobile, Inc." are "Device" (6 trials), "Drug" (4 trials), "Other" (3 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel administration using the OPC" (2 trials), "99mTechnicium (sestamibi or tetrofosmin)" (1 trials), "ACE-I (lisinopril) or ARB (losartan)" (1 trials), "Aspirin" (1 trials) and "Aveir DR Leadless Pacemaker System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiology Associates of Mobile, Inc." are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cardiology Associates of Mobile, Inc.". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Cardiology Associates of Mobile, Inc., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiology Associates of Mobile, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".

Cardiology Associates of Mobile, Inc. has several departments that took part in Clinical trials: "Cardiology Associates of Mobile" - 9 trials